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Abstract
A family of engineered endopeptidases has been created that is capable of cleaving a diverse array
of peptide sequences with high selectivity and catalytic efficiency (kcat/KM > 104 M−1 s−1). By
screening libraries with a selection-counterselection substrate method, protease variants were
programmed to recognize amino acids having altered charge, size and hydrophobicity properties
adjacent to the scissile bond of the substrate, including Glu↓Arg, a specificity that to our
knowledge has not been observed among natural proteases. Members of this artificial protease
family resulted from a relatively small number of amino acid substitutions that (at least in one
case) proved to be epistatic.
Around 2% of the mammalian genome encodes for enzymes involved in protein
degradation, underscoring the fundamental role of proteolysis in living organisms1.
Unregulated proteolysis in vivo is lethal, and hence there is a critical requirement for precise
sequence specificity as well as temporal and spatial control over protease activity2,3. The
generalizable ability to engineer a protease to cleave any desired peptide sequence in an
exquisitely selective manner and with high catalytic efficiency is of substantial interest for
analytical, biotechnological and even therapeutic applications4-7. Although the utility of
structure-guided mutagenesis to swap substrate preferences between homologous proteases
has been previously demonstrated8,9, the systematic engineering of protease specificity to
accommodate a diverse set of substrate sequences while maintaining high catalytic activity
has remained elusive. Furthermore, typical directed evolution efforts to modify substrate
preferences have given rise to enzymes exhibiting either relaxed selectivity or lower
turnover for the new substrate10,11. Herein we report the surprisingly general ability to
program a family of highly selective and active proteases with new substrate specificities at
both the P1 and P1′ positions, including sequences not recognized by the wild-type (WT)
enzyme. Using a dual-substrate selection-counterselection flow cytometric assay to screen
libraries derived from various diversification methods, protease variants were engineered to
be specific for scissile bonds comprised of amino acids having altered charge, size, and
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hydrophobicity, including Glu↓Arg, a specificity that does not appear to be preferred by any
reported naturally occurring protease.
RESULTS
Selection and counterselection strategies
The Escherichia coli surface endopeptidase OmpT likely plays multiple roles in virulence12
and exhibits a strong preference for cleavage between pairs of the basic amino acids lysine
and arginine (especially the latter), cleaving these pairs with high catalytic efficiency13.
Importantly, OmpT is not active until incorporated into the E. coli outer membrane,
minimizing host lethality14. A quantitative, single cell–based assay optimized for dynamic
range and sensitivity was developed to isolate only those OmpT variants capable of cleaving
a desired selection peptide substrate (SelSub), but not a counterselection substrate (CtsSub)
(Fig. 1a, ref. 15). Briefly, the SelSub is comprised of a BODIPY fluorophore and positively
charged groups on one side of the putative cleavage site and a quencher on the other.
Cleavage by surface-displayed enzyme results in release of the quencher moiety, thereby
enhancing BODIPY fluorescence. The fluorescent product, which has a +3 overall charge, is
electrostatically captured on the negatively charged E. coli surface. The CtsSub has a
positive charge and a tetramethylrhodamine (TMR) fluorophore on one side of a putative
cleavage site and only negative charge on the other (no quencher). Upon cleavage, the
negative charge is released, giving rise to an overall positively charged fluorescent product
that is again captured on the E. coli surface. Flow cytometry is used to isolate variants
exhibiting high BODIPY (green) fluorescence and little to no TMR (red) fluorescence.
We used this approach to engineer a family of OmpT variants with diverse specificities at
the P1 and/or P1′ residues of the substrate. We sought to isolate highly active variants
exhibiting kcat/KM > 104 M−1 s−1 for the cleavage of the SelSub substrates (Fig. 1b) and a
selectivity of at least 50-fold relative to the cleavage of the CtsSub that contains an Arg-Arg
sequence preferred by the WT enzyme.
Reversal of ion pair polarity at P1
Unexpectedly, and in contrast to earlier theoretical predictions16, the most tractable design
problem proved to be the reversal of ion pair polarity at P1. Notably, although ion pair
reversal has been attempted in the context of trypsin and granzyme B, the engineered
enzymes demonstrated no amide hydrolysis of the oppositely charged substrates17,18. Three
residues (Glu27, Asp208 and Ser223) were targeted by saturation mutagenesis because they
constitute the bottom of the presumed S1 pocket of OmpT (ref. 19). The resulting library (1
× 106 transformants) was screened using 20 nM SelSub 1a (Fig. 1), containing glutamate at
the putative P1 and arginine at P1′, and 100 nM CtsSub 5a, which contained an Arg-Arg
cleavage site. Cells exhibiting only high BODIPY fluorescence were isolated by four rounds
of flow cytometry, resulting in identification of variant ER-OmpT, which contained three
mutations that reversed the polarity of the S1 subsite (Fig. 2, Supplementary Fig. 1 online).
Purified ER-OmpT hydrolyzed the unlabeled peptide WCERVGKGRGR (1b) between
Glu↓Arg with high catalytic efficiency (kcat/KM = 3 ± 2 × 105 M−1 s−1, Table 1,
Supplementary Fig. 2 online). WT OmpT did not cleave 1b, and ER-OmpT did not cleave
the WT-preferred substrate 5b, which verifies that ER-OmpT satisfies the criteria for both
altered substrate selectivity and high catalytic efficiency, as defined above. To our
knowledge, no natural enzyme that selectively cleaves between Glu↓Arg has been reported,
and therefore ER-OmpT represents a new protease specificity20. The active site mutations
responsible for the switch in substrate selectivity of ER-OmpT were investigated
individually and found to be epistatic (Fig. 2).
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Aromatic and polar residue specificity at P1
The isolation of OmpT variants that specifically accept an aromatic (tyrosine) or polar
(threonine) amino acid in S1 required the use of more complex sequence diversification
strategies. Attempts to screen an error-prone PCR mutagenesis library or the Glu27, Asp208,
Ser223 saturation library with the SelSub (2a and 3a, respectively) and the CtsSub 5a failed
to yield variants with the desired activities. Therefore, a library that targets the 21 amino
acids lining the entire OmpT active site (excluding the putative catalytic residues Asp83,
Asp85, Asp210 and His212) was constructed via oligonucleotide-based gene assembly
reactions in which degenerate NNS (N = T,A,G,C; S = G or C) oligonucleotides (90 mol %)
were mixed with the WT oligonucleotides (10 mol %). The resulting library of 2 × 108
transformants was screened against SelSub 2a and CtsSub 5a. After six rounds of sorting,
the variant YR-OmpT (Supplementary Fig. 3 online) was isolated. This variant contained
seven amino acid substitutions and had aromatic residues replacing the acidic residues at the
bottom of the S1 subsite (Glu27Trp and Asp208His, Table 1). Purified YR-OmpT cleaved
the substrate peptide WCY↓RVGKGRGR (2b) with a kcat/KM = 8 ± 3 × 104 M−1 s−1, yet
did not cleave 5b.
To generate a variant specific for threonine in P1, a new saturation mutagenesis library
targeting the seven residues that constitute the entire putative S1 binding pocket
(Supplementary Table 1 online) was constructed (6 × 108 transformants). Four rounds of
flow cytometric screening with SelSub 3a and CtsSub 5a resulted in isolation of the low-
activity variant TR1-OmpT (Supplementary Fig. 3 online). Subsequent random mutagenesis
by error-prone PCR of the TR1-OmpT sequence (2 × 108 transformants) followed by three
rounds of flow cytometry yielded the highly active and selective variant TR2-OmpT (kcat/
KM, = 2 ± 1 × 104 M−1 s−1 for 3b), which contained nine amino acid substitutions relative to
WT OmpT (Table 1) and five substitutions relative to TR1-OmpT.
Valine specificity at P1′
In order to isolate a variant with an altered P1′ preference (valine), the Glu27, Asp208 and
Ser223 saturation library was screened with 2a. No CtsSub was used in this case because 5a
also contains an Arg-Val cleavage sequence. The best resulting variant, found to contain
only one amino acid substitution, S223D, was subjected to random mutagenesis (2 × 108
transformants). Following three rounds of sorting, a consensus variant, RV-OmpT, emerged.
RV-OmpT contained three amino acid substitutions (Table 1) and cleaved 2b with very high
efficiency: kcat/KM = 5 ± 2 × 105 M−1 s−1.
Engineered specificity at P1 and P1′
To change simultaneously the preference at both P1 and P1′, specifically to Glu↓Ala, ER-
OmpT was used as a template to construct an error-prone PCR library (1 × 108
transformants) that was subjected to five rounds of sorting with SelSub 4a and CtsSub 5a.
The result was the highly active variant EA-OmpT (Table 1), which exhibited the highest
catalytic efficiency of any variant isolated, displaying kcat/km = 1.0 ± 0.3 × 106 M−1 s−1 for
cleavage of the Glu-Ala sequence in 4b. Note that the preferred Glu↓Ala dipeptide sequence
for EA-OmpT is acidic and expected to have a −1 overall charge, whereas the WT OmpT–
preferred Arg↓Arg sequence has a +2 charge. Thus, the highest overall catalytic efficiency
seen in the study occurred with the variant specific for the largest change in chemical
properties at the substrate cleavage site.
Analysis of variant specificity
In order to investigate the extent to which counterselection with 5a led to exclusion of other
residues besides arginine at the cleavage site, the variants were incubated with several
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peptide substrates spanning a range of P1 residues (Table 2). Notably, the Ala↓Arg-specific
enzyme OmpT S223R we had reported earlier15 did not hydrolyze any of the alternative
substrates examined. The fine specificity of this enzyme was further analyzed by substrate
phage. Phage displaying a random octapeptide fused between the pIII protein, and a FLAG
tag peptide epitope was subjected to five rounds of panning21. A strong preference for
alanine in P1 was detected, with threonine as the only other amino acid at that position (data
not shown). The consensus sequence determined by sequencing 42 clones was
GLEA↓RRVG.
Similar to the S223R enzyme, ER-OmpT hydrolyzed only the substrate peptide containing
an ER sequence. The variants YR-OmpT and TR2-OmpT were capable of modest cleavage
at Ala-Arg and at Ala-Arg and Glu-Arg, respectively (Table 1), but did not cleave any of the
other substrates. Because these engineered variants did not cleave the Arg-Arg sequence
present in the CtsSub, it is reasonable to assume that additional rounds of counterselection
with the appropriate substrates could be used to achieve absolute or near-absolute specificity
for threonine and tyrosine with YR-OmpT and TR2-OmpT, respectively.
Biologically relevant functions of variants
Finally, we examined biologically relevant functions of the engineered enzymes. OmpT is
thought to be important for microbial virulence by virtue of its modest ability to activate
plasminogen and also its ability to cleave antimicrobial cationic peptides12. Since activation
of plasminogen to plasmin occurs through cleavage at Arg561↓Val562 (ref. 22), we
examined the plasminogen activation ability of the RV-OmpT variant. As expected, the RV-
OmpT variant exhibits high in vitro activity in the conversion of plasminogen to plasmin,
comparable to that displayed by the human tissue plasminogen activator (tPA)
(Supplementary Fig. 4 online)23.
The β-defensins are cationic antimicrobial peptides that consist of compactly folded β-sheets
held together by multiple disulfide bonds, which renders them resistant to bacterial
proteolysis24. The human β-defensin 3 (HBD-3) contains putative cleavage sites that can be
recognized by RV-OmpT and TR2-OmpT (Supplementary Fig. 5 online). In control
experiments, cells expressing WT OmpT showed 33-fold higher viability relative to
BL21(DE3) (ompT−ompP−) cells, which is consistent with its proposed role in cationic
antimicrobial peptide protection25. Similar expression of either RV-OmpT or TR2-OmpT
resulted in even greater survival, with a >2,000-fold increase in viability compared with
BL21(DE3) in the HBD-3 assay (Supplementary Table 2 online). Though RV-OmpT has
higher plasminogen activation and antimicrobial peptide activities in vitro, it remains to be
seen whether bacteria that express this enzyme are hypervirulent.
DISCUSSION
Although the Omptin family of enzymes, which includes OmpT, has evolved to favor
strongly basic residues in both P1 and P1′, one or two rounds of sequence diversification and
high-throughput screening readily yielded OmpT variants (Fig. 3) that are programmed to
recognize different side chains of P1 spanning the entire range of chemical properties
(aromatic, acidic, polar, small hydrophobic). These results demonstrate that, at least for
OmpT, a relatively small set (<3% of the sequence) of amino acid substitutions can result in
substantial alterations in substrate specificity, even toward sequences not recognized by the
WT enzyme. Notably, this included the generation of a variant with a substrate preference
(Glu↓Arg) not reported in any natural protease.
The enzyme variants isolated here do not exhibit the relaxed specificity or low activity of
primeval “generalist” enzymes that are typically obtained by standard laboratory-directed
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evolution11,26. Rather, the variants isolated all showed high catalytic activity and represent
“specialists”27-29 displaying selectivity comparable to or greater than WT OmpT. Based on
our analysis of mutations responsible for specificity in ER-OmpT, such jumps in protein
fitness leading directly from one specialist state to another without passing through a
generalist intermediate might hinge on epistatic mutations, isolation of which required
focused mutagenesis of specific sets of residues coupled to screening of relatively large
libraries.
Although the nature of mutations responsible for conferring modified selectivity to OmpT
appears to be straightforward—for example, aromatic residues in the S1 pocket to help
recognize P1 tyrosine—picking the right residues to rationally modify selectivity can be
challenging. Furthermore, the presence of epistatic interactions, as demonstrated with ER-
OmpT, makes the problem much more complex. Hence, we believe that the generalizable
alteration of substrate selectivity in other protease scaffolds can be achieved combinatorially
and is currently limited by the ability to design and implement high-throughput assays and
selections.
The engineering of a family of highly active and selective proteases with programmed
specificities reported here has important implications for analytical, biotechnological and
therapeutic applications. For example, as opposed to antibodies that simply bind a
therapeutic epitope in a stoichiometric fashion, a properly engineered protease would offer
the considerable advantage of being able to inactivate that same epitope in a catalytic
fashion. The result would be a significantly more efficient protein therapeutic, allowing for
substantially lower therapeutic doses, thereby saving treatment costs as well as minimizing
chances for adverse immunological reactions. To achieve the high selectivity needed for the
specific cleavage of therapeutic targets, it will probably be necessary to recognize residues
beyond the P1 and P1′ positions, and, as discussed above, multiple CtsSubs might be needed
to achieve optimal selectivity. Nonetheless, our results indicate that the engineering of
protease families with finely tailored specificity and catalytic properties is a tractable
problem.
METHODS
Flow cytometric OmpT activity assays
Single colonies were used to inoculate 2 ml 2× YT cultures supplemented with 200 μg ml−1
of ampicillin. The cells were harvested and resuspended in 1% sucrose as described
previously15. For labeling, 50 μl of the cells were diluted into 949 μl of sucrose and 1 μl of
the substrate (final concentration 20 nM for 1a–4a and 100 nM for b). A 20 μl aliquot of the
labeling reaction was diluted into 0.5 ml of 1% sucrose and analyzed on Becton Dickinson
FACS Sort.
Determination of the relative substrate specificities
30 μM of the appropriate substrate was incubated with 1–20 nM enzyme for 45 min such
that the enzyme cleaved the preferred substrate 40–50%. Reaction conditions were
optimized for each enzyme-substrate pair, and the percentage cleavage was estimated by
HPLC. The relative substrate preferences are reported as a percentage or ratio of the
preferred substrate cleavage.
Plasminogen activation assays
Stock solutions of Spectrozyme PL (5.0 mM) (American Diagnostica) and human glu-type
plasminogen (0.5 mg ml−1) were made in 50 mM Tris, 0.01% Tween 20, pH 7.4. To make
up the working solution, 5 ml of Spectrozyme PL (final concentration 0.5 mM) and 1 ml of
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plasminogen were added to 44 ml of 50 mM Tris, 0.01% Tween 20, pH 7.4. 0.2–5.0 μg of
the purified enzyme (tPA (American Diagnostica)/RV-OmpT/OmpT) were added to 200 μl
of the working solution, and the reaction kinetics were monitored at 405 nm on a BioTek
Synergy HT (BioTek Instruments) at 37 °C. In order to estimate whether the enzymes had
any activity toward hydrolyzing the chromogenic substrate, identical assays were run in the
absence of plasminogen.
Other methods
Protocols for substrate conjugation, library construction and screening30,31, enzyme
purification and kinetics, and β-defensin assays32 are described in the Supplementary
Methods online.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Screening methodology and the substrates used for screening. (a) Two-color flow
cytometric assay used for the isolation of OmpT variants with altered specificities. (b)
Amino acid sequence of the selection and counterselection substrates used for library
screening via flow cytometric assay (1a–5a) and for kinetic characterization by HPLC (1b–
5b). BD, BODIPY; Q, QSY7.
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Figure 2.
Flow cytometric data. Fluorescence histograms of E. coli BL21(DE3) with no expression
plasmid, cells expressing ER-OmpT, and the single-amino-acid variants E27L, D208R and
S223G with 1a.
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Figure 3.
Summary of sequence randomization strategy and library screening leading to the isolation
of highly active and selective OmpT variants. *From ref. 15.
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Table 1
Kinetic characterization of the OmpT variants
Enzyme Mutations Substrate, cleavage site kcat/KM (M−1 s−1)
WT OmpT – 5b, Arg↓Arg 2 ± 1 × 104
ER-OmpT E27L, D208R, S223G, L183Fa 1b, Glu↓Arg 3 ± 2 × 105
YR-OmpT E27W, V29P, I170V, Y172V, D208H, Y221A, L265V 2b, Tyr↓Arg 8 ± 0.5 × 104
TR2-OmpT E27H, V29S, D208L, D214N, S223D, P243S, W253G, N270Y, S276G 3b, Thr↓Arg 2 ± 1 × 104
RV-OmpT D97H, S223D, Q63R 2b, Arg↓Val 5 ± 2 × 105
EA-OmpT E27L, N48D, L183F, D208R, D214N, G216E, S223G, N244I, D274G, A280E 4b, Glu↓Ala 1.0 ± 0.3 × 106
Amino acid substitutions and enzyme kinetics with the preferred substrate for each of the OmpT variants described here.
a
L183F is a non-active site mutation that lies on the outside the β-barrel. Data represent the best fit of three independent measurements ± s.d.
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